Linerixibat decreased serum interleukin-31 levels in patients with primary biliary in cholangitis after 24 weeks, which may ...

In this video, Nancy S. Reau, MD, FAASLD, AGAF, discusses the impact of linerixibat on potential mediators of pruritus in patients with primary biliary cholangitis from the phase 3 double-blind, ...

Researchers created a dissolvable microneedle patch that delivers IL-4 directly to damaged heart tissue, jump-starting repair ...

Active component of HCW9302 is interleukin-2 -- cytokine that maintains proper numbers and functions of regulatory T cells to control excessive inflammation Gateway to development of a first-in-kind ...

Background Eosinophilic oesophagitis (EoE) is a chronic allergic disease characterised by oesophageal epithelial remodelling, barrier dysfunction and inflammation. The transcription factor forkhead ...

First Patient Dosed at The Ohio State University Wexner Medical Center in this Multi-Center Trial Active component of HCW9302 is interleukin-2 -- cytokine that maintains proper numbers and functions ...

Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company fully dedicated to developing IL-1ß-based treatments for immune-mediated inflammatory diseases, today announced the ...

Researchers at the University of Illinois Urbana-Champaign report that extracellular vesicles released into the bloodstream ...

In this real world cohort, tralokinumab for dupilumab nonresponders reduced body surface area and pruritus scores and eased ...

While ginger has potent anti-inflammatory properties, other foods may also deliver comparable or even greater anti-inflammatory benefits.

HCW Biologics Inc. (the "Company" or "HCW Biologics") (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing ...

A new patch developed by researchers at Texas A&M University may offer a promising way to help the heart heal after a heart attack. Led by Dr. Ke Huang, the team created a tiny microneedle patch that ...